Targeted Biomolecule Regulation Platform: A Split-and-Mix PROTAC Approach.
Fenfang YangQinhong LuoYuechen WangHuiting LiangYaqi WangZhanfeng HouChuan WanYuena WangZhihong LiuYuxin YeLizhi ZhuJianlong WuFeng YinZigang LiPublished in: Journal of the American Chemical Society (2023)
The development of bifunction al molecules, which can enable targeted RNA degradation, targeted protein acetylation, or targeted protein degradation, remains a time-consuming process that requires tedious optimization. We propose a split-and-mix nanoplatform that serves as a self-adjustable platform capable of facile screening, programmable ligand ratios, self-optimized biomolecule spatial recognition, and multifunctional applications. Herein, we demonstrate the potential of our proposed nanoplatform by showcasing proteolysis-targeting chimeras (PROTACs), namely, split-and-mix PROTAC (SM-PROTAC). We highlight the scope of our platform through the targeted disruption of intracellular therapeutic targets involving ERα, CDK4/6, AR, MEK1/2, BRD2/4, BCR-ABL, etc. These studies confirm the effectiveness and universality of the SM-PROTAC platform for proximity-induced applications. This platform is programmable, with significant potential applications to biomolecule regulation, including the fields of epigenetics, gene editing, and biomolecule modification regulation.
Keyphrases
- cancer therapy
- drug delivery
- high throughput
- photodynamic therapy
- systematic review
- tyrosine kinase
- randomized controlled trial
- protein protein
- risk assessment
- human health
- signaling pathway
- small molecule
- metal organic framework
- chronic myeloid leukemia
- drug release
- gold nanoparticles
- highly efficient
- reactive oxygen species
- pi k akt